NIH-funded research Sbir 2 grant

Using a self-collect device for cervical cancer screening

Official title: Evaluation of the Teal self-collect device for cervical cancer screening

Funded at Teal Health INC · NIH-11008315 · Data updated 2026-11-12

This study is looking at a new device called the Teal Wand that lets women collect their own samples at home for HPV testing, making it easier for them to get screened for cervical cancer, especially if they have trouble accessing traditional healthcare.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionTeal Health INC
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 23, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$1,114,893
NIH project number1R44CA291336-01A1
Project IDNIH-11008315 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women who are eligible for cervical cancer screening and may benefit from at-home testing options.

Less likely to help

Patients who have already been diagnosed with cervical cancer or those who do not require screening will not benefit from this research.

What this research studies

This research investigates the Teal self-collect device, which allows women to collect their own vaginal samples for HPV testing, a key factor in cervical cancer prevention. The device features a textured sponge designed to gather sufficient cellular material and preserve samples for accurate testing. By enabling at-home sample collection, the Teal Wand aims to increase participation in cervical cancer screening, particularly among women facing access barriers. The study seeks FDA approval for this innovative device to facilitate telehealth visits and improve preventive care access.

Why it matters

Potential benefit: If successful, this research could significantly increase cervical cancer screening rates among women, particularly those with limited access to traditional healthcare services.

How similar studies have gone: Similar approaches to self-collection for HPV testing have shown promise in increasing screening rates, indicating potential success for this novel device.

Where this research is happening

  • Teal Health INC
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Fitzpatrick, Megan — Teal Health INC
  • Study coordinator: Fitzpatrick, Megan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.